Related Experiment Video
Updated: Mar 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
[Invasive pulmonary aspergillosis in non-neutropenic patients]
M I Tejeda, S Salso, J Barberán1
1José Barberán, Hospital Madrid Universitario Montepríncipe Universidad CEU San Pablo, Madrid, Spain. barberan60@gmail.com.
Abstract:
The incidence of invasive pulmonary aspergillosis (IPA) is increasing among non-neutropenic patients in recent years. The difficulty of early diagnosis in these patients involves a delay in the onset of adequate treatment and higher mortality.
Insights
Invasive pulmonary aspergillosis (IPA) is rising in non-neutropenic patients. Early diagnosis is crucial to improve treatment and reduce mortality in this vulnerable group.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Invasive pulmonary aspergillosis (IPA) incidence is increasing.
- This rise is particularly noted in non-neutropenic patient populations.
- Early diagnosis of IPA in these patients remains a significant challenge.
Purpose of the Study:
- To highlight the diagnostic challenges of IPA in non-neutropenic patients.
- To emphasize the impact of delayed diagnosis on treatment and outcomes.
- To underscore the need for improved diagnostic strategies for IPA.
Main Methods:
- Literature review on recent trends in IPA.
- Analysis of diagnostic difficulties in non-neutropenic cases.
- Review of treatment delays and mortality rates associated with IPA.
Main Results:
- IPA is increasingly diagnosed in non-neutropenic individuals.
- Diagnostic delays are common in this patient group.
- Delayed treatment initiation correlates with increased mortality.
Conclusions:
- The rising incidence of IPA in non-neutropenic patients necessitates urgent attention.
- Overcoming diagnostic hurdles is critical for timely and effective IPA treatment.
- Improved diagnostic approaches are essential to reduce IPA-related mortality.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Fungal Phylum Ascomycota
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

